SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) -- Ignore unavailable to you. Want to Upgrade?


To: Anthony Wong who wrote (1555)3/30/1999 7:22:00 PM
From: Anthony Wong  Read Replies (1) | Respond to of 1722
 
03/30 16:45 Searle's Celebrex weekly prescriptions top Viagra

CHICAGO, March 30 (Reuters) - Weekly prescriptions for the new
arthritis drug, Celebrex, from Monsanto's <MTC.N> G.D. Searle unit
rose to more than 320,000, topping the best week ever for Pfizer's
anti-impotence drug Viagra, according to new data.

NDC Health Information Services said for the week ended Sunday,
the 10th week the product was on the market, Celebrex prescriptions
totalled 322,000, which compared with 310,000 prescriptions for
Viagra during its best-selling week. Celebrex's new prescription
market share reached another high on Thursday and Friday of last
week at nearly 24 percent, the organization said.

moneynet.com@NEWS-P1&Index=2&HeadlineURL=../News/NewsHeadlines.asp&DISABLE_FORM=&NAVSVC=News\Company



To: Anthony Wong who wrote (1555)4/6/1999 10:47:00 PM
From: DavesM  Read Replies (1) | Respond to of 1722
 
AstraZeneca symbol AZN